| |
| |
| |
General principles | |
| |
| |
| |
What is pharmacology? | |
| |
| |
| |
How drugs act: general principles | |
| |
| |
| |
How drugs act: molecular aspects | |
| |
| |
| |
How drugs act: cellular aspects-excitation, contraction and secretion | |
| |
| |
| |
Cell proliferation, apoptosis, repair and regeneration | |
| |
| |
| |
Cellular mechanisms: host defence | |
| |
| |
| |
Method and measurement in pharmacology | |
| |
| |
| |
Drug absorption and distribution | |
| |
| |
| |
Drug metabolism and elimination | |
| |
| |
| |
Pharmacokinetics | |
| |
| |
| |
Pharmacogenetics, pharmacogenomics and 'personalised medicine' | |
| |
| |
| |
Chemical mediators | |
| |
| |
| |
Chemical mediators and the autonomic nervous system | |
| |
| |
| |
Cholinergic transmission | |
| |
| |
| |
Noradrenergic transmission | |
| |
| |
| |
5-Hydroxytryptamine and the pharmacology of migraine | |
| |
| |
| |
Purines | |
| |
| |
| |
Local hormones: cytokines, biologically active lipids, amines and�peptides | |
| |
| |
| |
Cannabinoids | |
| |
| |
| |
Peptides and proteins as mediators | |
| |
| |
| |
Nitric oxide | |
| |
| |
| |
Drugs affecting major organ systems | |
| |
| |
| |
The heart | |
| |
| |
| |
The vascular system | |
| |
| |
| |
Atherosclerosis and lipoprotein metabolism | |
| |
| |
| |
Haemostasis and thrombosis | |
| |
| |
| |
Haemopoietic system and treatment of anaemia | |
| |
| |
| |
Anti-inflammatory and immunosuppressant drugs | |
| |
| |
| |
The respiratory system | |
| |
| |
| |
The kidney | |
| |
| |
| |
The gastrointestinal tract | |
| |
| |
| |
The control of blood glucose and drug treatment of diabetes mellitus | |
| |
| |
| |
Obesity | |
| |
| |
| |
The pituitary and the adrenal cortex | |
| |
| |
| |
The thyroid | |
| |
| |
| |
The reproductive system | |
| |
| |
| |
Bone metabolism | |
| |
| |
| |
The nervous system | |
| |
| |
| |
Chemical transmission and drug action in the central nervous system | |
| |
| |
| |
Amino acid transmitters | |
| |
| |
| |
Other transmitters and modulators | |
| |
| |
| |
Neurodegenerative diseases | |
| |
| |
| |
General anaesthetic agents | |
| |
| |
| |
Analgesic drugs | |
| |
| |
| |
Local anaesthetics and other drugs affecting sodium channels | |
| |
| |
| |
Anxiolytic and hypnotic drugs | |
| |
| |
| |
Antiepileptic drugs | |
| |
| |
| |
Antipsychotic drugs | |
| |
| |
| |
Antidepressant drugs | |
| |
| |
| |
CNS stimulants and psychotomimetic drugs | |
| |
| |
| |
Drug addiction, dependence and abuse | |
| |
| |
| |
Drugs used for the treatment of infections, cancer and immunological disorders | |
| |
| |
| |
Basic principles of antimicrobial chemotherapy | |
| |
| |
| |
Antibacterial drugs | |
| |
| |
| |
Antiviral drugs | |
| |
| |
| |
Antifungal drugs | |
| |
| |
| |
Antiprotozoal drugs | |
| |
| |
| |
Anthelminthic drugs | |
| |
| |
| |
Anticancer drugs | |
| |
| |
| |
Special topics | |
| |
| |
| |
Individual variation and drug interaction | |
| |
| |
| |
Harmful effects of drugs | |
| |
| |
| |
Lifestyle drugs and drugs in sport | |
| |
| |
| |
Biopharmaceuticals and gene therapy | |
| |
| |
| |
Drug discovery and development | |